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Summary 
QUESTIONS UNDER STUDY: Chronic pain has a high im-
pact on individuals and society. (Cost-)effective inter-
ventions are desperately needed. We evaluated short- 
and long-term effects of the Bern Ambulatory Interpro-
fessional Rehabilitation (BAI-Reha) for patients with 
chronic musculoskeletal pain. 
METHODS: We analysed data prospectively collected 
from patients with chronic musculoskeletal pain before 
and after BAI-Reha (at 12 weeks, 1 year and 2 years) us-
ing linear mixed-models and logistic generalised esti-
mating equations. 
RESULTS: The first thirty consecutive patients with 
chronic musculoskeletal pain, aged between 20 and 73 
years (mean 44.83, standard deviation 12.57 years) 
were included. We found significant changes over time 
compared with baseline for return to work (p <0.001), 
Euro quality of life visual analogue scale score (p = 
0.026), burden of suffering (p = 0.001), self-rated and 
observed quality of daily life task motor performance (p 
<0.001 and p = 0.012, respectively) but not for pain in-
tensity (p = 0.16) and observed quality of daily life task 
process performance (p = 0.28). At the first postinter-
vention visit we found significant differences compared 
with baseline in return to work (odds ratio 5.26, 95% 
confidence interval [CI] 1.80–15.39], burden of suffering 
(mean difference 5.26, 95% CI 2.09–8.44], self-rated 
quality (mean difference 2.31, 95% CI 1.57–3.05) and 
satisfaction (mean difference 2.80, 95% CI 1.95-3.66) 
with daily life task performance, and observed quality 
with daily life task motor performance (mean difference 
0.31, 95% CI 0.02–0.60). 
CONCLUSIONS: This study confirms earlier data and sup-
ports the effectiveness of interprofessional rehabilita-
tion for patients with chronic musculoskeletal pain. 
Key words: musculoskeletal rehabilitation, ambulatory, 
interdisciplinary, multiprofessional, biopsychosocial 
Introduction 
Chronic pain has a high impact on individuals, their fam-
ilies, employers and society. In Switzerland, it is esti-
mated that low back pain leads to direct health care costs 
of CHF 3.8 billion (EUR 3.5 billion) and indirect costs of 
CHF 7.4 billion (EUR 6.8 billion) per year [1]. In addi-
tion to the financial aspects, the chronification of pain has 
a fundamental impact on work [2], social relations [3] 
and performance of activities of daily living (ADL) [4]. 
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The range of treatment modalities for patients with 
chronic pain is wide. It includes drugs, single interven-
tions such as information, education, physio- and occu-
pational therapy, surgical procedures and placebo thera-
pies, and also interprofessional/interdisciplinary rehabil-
itation programmes [5]. Within the last decade several 
randomised controlled trials have shown that interprofes-
sional interventions are more effective than single inter-
ventions in patients suffering from chronic pain and di-
agnosed with ankylosing spondylitis [6], back and neck 
pain [7], fibromyalgia [8–11], low back pain [12–16] or 
migraine [17]. However, according to a recent Cochrane 
review the intervention effect in these trials is moderate 
[18]. 
There are inherent problems in designing randomised 
controlled trials for chronic musculoskeletal pain. As the 
time-curve of return to work decreases exponentially, it 
may be considered unethical to run a control group over 
a period of more than 6 months with no interventions at 
all or with interventions proven to be of little effect. In 
addition, the contribution of the well-defined variables 
promoting chronification vary from patient to patient. 
Thus, very large patient numbers would be necessary to 
generate reliable data. Costs of such large randomised 
controlled trials are not covered by pharmaceutical com-
panies. As an alternative approach, cohort studies with a 
wide range of outcome variables allow evaluation of the 
effectiveness of well-defined rehabilitation programmes 
over time [19]. 
We decided to analyse the short-, medium- and long-term 
effects on the first thirty patients participating in our am-
bulatory rehabilitation programme, the Bern Ambulatory 
Interprofessional Rehabilitation (BAI-Reha). The data 
were extracted from a range of predefined assessments 
and clinical variables. We calculated the effects on return 
to work, pain intensity, quality of life, burden of suffer-
ing, self-rated and observed quality of and satisfaction 
with daily life task performance. 
Methods 
Design 
This was a cohort study. Data were extracted from patient 
records at the University Hospital of Bern. Patients 
started the BAI-Reha programme between March and 
November 2013 and were followed-up in a standardised 
fashion using validated assessment tools, until November 
2015. The use of anonymised data for this study was ap-
proved by the Ethics Review Board Bern (121/15). 
Participants 
Patients admitted for participation in the BAI-Reha pro-
gramme were assessed in an in-patient setting for 48 
hours. Physicians, nurses, occupational and physiothera-
pists, psychologists and social workers used validated 
tools in a standardised work-up. Based on the results, the 
team judged conjointly whether the patients should be in-
cluded in the BAI-Reha programme or whether other 
treatment/rehabilitation modalities were more suitable. 
The patients were thoroughly informed and included in 
the programme only if they showed genuine motivation 
and agreed to perform the whole programme. (Infor-
mation leaflets about the programme can be downloaded 
from our website www.rheumabern.ch). Criteria for in-
clusion were: (1) age between 18 and 75 years; (2) diag-
nosis of chronic musculoskeletal pain syndrome accord-
ing to ICD-10 criteria [20] with chronic pain either (a) 
associated with actual or potential tissue damage or (b) 
associated with tissue damage and a mental disorder; (3) 
indicators of significant impairment in psychosocial 
functions; (4) dominance of somatic disease aspects over 
psychological/psychiatric problems such as depression; 
(5) obvious interest of the patient; and (6) rehabilitation 
potential. The exclusion criteria were: (1) a primary men-
tal disorder, (2) refusal to participate in an interprofes-
sional outpatient rehabilitation, (3) limited skills to ac-
tively participate in group discussions held in German, 
and (4) involvement in ongoing legal proceedings about 
health insurance benefits. 
Setting, staff and location 
The study took place in Switzerland at the Department of 
Rheumatology, Immunology and Allergology of the Uni-
versity Hospital Bern. This department provides interpro-
fessional inpatient and outpatient medical and rehabilita-
tion services for patients with various diagnoses, includ-
ing patients with chronic musculoskeletal pain. All inter-
professional interventions but one were implemented in 
the ambulant setting of the department. The work place 
visits and interventions were conducted at patients’ reg-
ular work places. 
Interventions 
The BAI-Reha programme is a complex interprofessional 
intervention lasting 12 weeks (table 1). It consists of three 
phases of 4 weeks each. It was developed on the basis of 
evidence and international guidelines, and includes sin-
gle and group interventions and independent self-directed 
exercises. The goals are defined at start by the team to-
gether with the participant and they are readjusted 
monthly during the course of rehabilitation with congru-
ent modifications of the interventions. For example, if a 
client aims at working again, at the beginning the inter-
ventions focus on body awareness and ergonomic pos-
tures; after resuming part-time work, the focus is adjusted 
to pause management and releasing postures as well as 
physical reconditioning. During the first 4 weeks, pa-
tients are requested not to engage in co-interventions. Af-
terwards, they continue with independent self-directed 
exercises. 
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Table 1: Content of interprofessional intervention in BAI-Reha phases one to three: description and intensity of interventions. 
 Description of interventions Total duration (h) 
Phase one: 
1st week to 4th week 
Individual interventions  
Medical treatment 4 
Occupational therapy 4 
Physical therapy 4 
Behavioural therapy 4 
Social worker’s intervention 4 
Interprofessional meetings 2 
Group interventions  
Group exercises 10 
Behavioural therapy group intervention 6 
Occupational therapy groups (e.g., cooking) 12 
Body-awareness group 4 
Swimming 4 
Nordic walking 4 
Total hours of interprofessional intervention 62 
Phase two: 
5th week to 8th week 
Individual interventions  
Specific individual interventions based on the individual needs of participants: med-
ical treatment, occupational, physical and/or behavioural therapy 
12 
Workplace visit and intervention 4 
Group interventions  
Group exercises 10 
Supervision of independent self-directed exercises 2 
Independent self-directed exercises* 14 
Total hours of interprofessional intervention 28 
Phase three: 
9th week to 12th week 
Individual interventions  
Specific individual interventions based on the individual needs of participants: med-
ical treatment, occupational, physical and/or behavioural therapy 
5 
Interprofessional meetings 1 
Group intervention  
Group exercises 10 
Independent self-directed exercises 14 
Supervision of the independent self-directed exercises 2 
Total hours of interprofessional intervention 18 
All phases Total hours of interprofessional intervention 108 
* The hours needed for independent self-directed exercises are not calculated as part of the total hours of interprofessional interventions. 
 
 
Phase one consists of 20 hours of single interventions 
and 40 hours of group interventions. The aim of this 
phase is to acquire fundamental information about pain, 
to learn strategies and acquire competences in order to 
cope with the pain and increase activity and participation 
in different areas of life, and to increase physical condi-
tion. The participants are usually on sick leave during this 
phase. 
Phase two is characterised by consolidation of strategies 
and increasing competence of participants. The time for 
interprofessional interventions is decreased and the time 
for independent self-directed exercises is increased. The 
self-directed exercises are developed together with the 
patients in relation to their individual goals and are rec-
orded in the patient’s own words in an individual training 
book. So-called activity-pacing (e.g., walking through 
the woods or household activities like ironing or hoover-
ing) is a method often used in occupational therapy. A 
common method in physiotherapy is re-establishment of 
muscular balance by stretching a tense antagonist (e.g., 
the descending part of the trapezius muscle), while acti-
vating a weak agonist (e.g., the ascending part of the mus-
cle). In phase two the participants who are employed 
gradually start work training at their regular workplace. 
An occupational therapist assesses the worksite, holds 
discussions with the employers and recommends work 
adaptations (e.g., adaptation of workplace, work tasks 
and ergonomics). 
Phase three is characterised by increased competences of 
participants to cope with the pain in daily life. They re-
ceive 2 to 5 hours of specific individual interventions (if 
needed) and 10 hours group interventions during these 4 
weeks. They are encouraged to continue their independ-
ent self-directed exercises, to establish long-term physi-
cal training and to increase their work participation. 
Outcomes 
The primary outcome was return to work as this is the 
most important health-economic and integrative measure 
[18]. 
Secondary outcomes were the EuroQoL-5D-3L VAS 
(European Quality of Life and Health measure) [21, 22], 
the Numeric Rating Scale (NRS) [23], the Assessment of 
Motor and Process Skills (AMPS) [24], the Canadian Oc-
cupational Performance Measure (COPM) [25], and the 
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Pictorial Representation of Illness and Self Measure 
(PRISM) [26]. 
The EuroQoL is a standardised outcome measure of qual-
ity of life and health status for clinical and economical 
appraisal [21]. It provides a descriptive profile and a vis-
ual analogue scale (EuroQoL VAS) for a person’s health 
status, including those with chronic pain [27]. The NRS 
(Numeric Rating Scale) is an 11-point scale from 0–10, 0 
standing for no pain and 10 standing for the most intense 
pain imaginable [23]. Patients select a value corresponds 
to the intensity of their current pain. The AMPS is an in-
ternationally standardised, observational assessment of 
the quality of activities of daily living (ADL) motor and 
ADL process task performance [24, 28]. There is exten-
sive evidence to support the reliability and validity of the 
AMPS measures, including validity for use with patients 
with chronic pain [e.g., 4]. The COPM [25] is a semi -
structured interview used to evaluate participants’ per-
ception of quality and satisfactoriness of task perfor-
mance over time [25]. The PRISM is a tool used to graph-
ically represent the burden of an illness in relation to one-
self and one’s life measured with the Self-Illness-Separa-
tion (SIS) instrument [26, 29, 30]. All outcome measures 
were administered at baseline, at 12 weeks from baseline 
(post-treatment), and at 1 and 2 years by the team who 
provided the interventions during the BAI-Reha pro-
gramme. 
Sample size 
We decided to evaluate the programme using data from 
the first 30 consecutive participants enrolled in the first 
seven groups of the BAI-Reha programme and having 
been followed over 2 years. 
Statistical methods 
Demographic data of participants was analysed with de-
scriptive statistical methods. 
Continuous endpoints were analysed using linear mixed 
models with time-point as fixed covariate and a random 
intercept and slope for each patient. Models were fitted 
with restricted maximum likelihood (REML) and the Sat-
terthwaite approximation was used to calculate the de-
grees of freedom. Results are presented as a mean differ-
ence from baseline at each time-point with 95% confi-
dence interval (CI) and a p-value for the overall effect of 
time (from a joint test of the main effects of time). The 
binary endpoint (return to work) was fitted with logistic 
generalised estimating equations (GEE) with an unstruc-
tured correlation matrix. The results are presented as 
odds ratio (OR) compared with baseline with a 95% CI 
and a p-value for the overall effect of time (from a joint 
test of the main effects of time), which is reported in table 
3. 
The statistical analyses were planned and implemented 
by a researcher and a clinical statistician who were not 
otherwise involved in the BAI-Reha programme. All sta-
tistical analyses were done with Stata version 14 
(StataCorp. 2015. Stata Statistical Software: Release 14. 
College Station, TX: StataCorp LP.). A level of signifi-




Table 2: Demographic characteristics of the 30 participants. 
 n % 
Gender   
Female 13 (43) 
Male 17 (57) 
Diagnosis 
  
Gonarthrosis 1 (3.3) 
Arthrosis, primary 1 (3.3) 
Pain in joint 3 (10) 
Ankylosing spondylitis 2 (6.6) 
Cervicobrachial syndrome 4 (13) 
Low back pain 17 (56) 
Gluteal tendinitis 1 (3.3) 
Other soft tissue disorders 1 (3.3) 
Language preference 
  
German 25 (83) 
Other 5 (17) 
Educational level completed 
  
Primary education 0 (0) 
Lower secondary education* 10 (33) 
Upper secondary education* 20 (67) 
Post-secondary education* 0 (0) 
Tertiary education* 0 (0) 
Living situation 
  
Single 17 (56.7) 
Partner and/or family 13 (43.3) 
Total 30 (100) 
* Educational levels are based on International Standard Classification of Education (ISCED 2011) levels of education [31] 
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Results 
A total of 30 patients with chronic pain, between the ages 
of 20 and 73 years (mean 44.83, standard deviation [SD] 
12.57 years) participated in this study (demographic data 
of participants are summarised in table 2). 
Logistic GEE and linear mixed model analysis revealed 
a significant change for return to work (p <0.001), Eu-
roQoL VAS (p = 0.026), burden of suffering due to 
chronic pain (PRISM, p = 0.001), self-rated quality and 
satisfaction with daily life performance (COPM perfor-
mance, p <0.001 and COPM satisfaction, p <0.001) and 
observed quality of daily life task motor performance 
(AMPS ADL motor, p <0.001). No significant time ef-
fects over 2 years were found for pain intensity (p = 0.16) 
and observed quality of daily life task process perfor-
mance (AMPS ADL process p = 0.28) (table 3). At the 
first postintervention visit we found significant differ-
ences compared with baseline in return to work (OR 5.26, 
95% CI 1.80–15.39], burden of suffering (OR5.26, 95% 
CI 2.09–8.44], self-rated quality (OR 2.31, 95% CI 1.57-
3.05] and satisfaction (2.80, 95% CI 1.95–3.66) with 
daily life task performance, and observed quality with 
daily life task motor performance (OR 0.31, 95% CI 
0.02–0.60] (table 3). Similar effects were found at the 1-





Table 3: Mean differences or odds ratio compared with baseline at each time point with 95% confidence interval and p-value for the overall 
effect on time.  
No. of patients Mean (SD) or n (%) Mean difference or odds ratio (95% CI) p-value† 
Return to work* 
   
<0.001 
Baseline 27 4 (15%) 1 (Ref) 
 
Post-treatment 26 12 (46%) 5.26 (1.80 to 15.39) 
 
1-year follow-up 26 14 (54%) 7.09 (2.33 to 21.56) 
 
2-year follow-up 26 17 (65%) 11.4 (3.5 to 36.9) 
 
Qol VAS 
   
0.026 
Baseline 24 48.8 (17.8) 0 (Ref) 
 
Post-treatment 23 58.3 (17.5) 9.00 (˗0.47 to 18.47) 
 
1-year follow-up 21 54.2 (21.4) 4.15 (˗5.84 to 14.14) 
 
2-year follow-up 24 63.1 (16.5) 14.3 (4.1 to 24.5) 
 
PRISM 
   
0.001 
Baseline 23 4.97 (2.61) 0 (Ref) 
 
Post-treatment 22 10.3 (7.8) 5.26 (2.09 to 8.44) 
 
1-year follow-up 24 11.2 (7.6) 6.26 (2.79 to 9.73) 
 
2-year follow-up 20 11.5 (8.2) 6.06 (1.81 to 10.31) 
 
COPM performance 
   
<0.001 
Baseline 30 3.32 (1.29) 0 (Ref) 
 
Post-treatment 26 5.63 (1.94) 2.31 (1.57 to 3.05) 
 
1-year follow-up 26 6.19 (1.80) 2.74 (1.89 to 3.59) 
 
2-year follow-up 21 6.08 (2.23) 2.74 (1.66 to 3.82) 
 
COPM satisfaction 
   
<0.001 
Baseline 30 2.68 (1.48) 0 (Ref) 
 
Post-treatment 26 5.52 (2.25) 2.80 (1.95 to 3.66) 
 
1-year follow-up 26 6.18 (2.23) 3.38 (2.42 to 4.34) 
 
2-year follow-up 21 6.32 (2.39) 3.61 (2.40 to 4.82) 
 
Pain intensity 
   
0.16 
Baseline 29 4.90 (2.47) 0 (Ref) 
 
Post-treatment 19 5.11 (2.47) 0.38 (˗0.70 to 1.46) 
 
1-year follow-up 26 5.08 (2.15) 0.26 (˗0.71 to 1.23) 
 
2-year follow-up 27 4.26 (2.33) ˗0.69 (˗1.66 to 0.27) 
 
AMPS ADL motor 
   
0.012 
Baseline 25 1.92 (0.36) 0 (Ref) 
 
Post-treatment 24 2.24 (0.71) 0.31 (0.02 to 0.60) 
 
1-year follow-up 20 2.37 (0.55) 0.49 (0.14 to 0.83) 
 
AMPS ADL process 
   
0.28 
Baseline 25 1.25 (0.23) 0 (Ref) 
 
Post-treatment 23 1.33 (0.26) 0.08 (˗0.07 to 0.23) 
 
1-year follow-up 19 1.38 (0.32) 0.13 (˗0.04 to 0.29) 
 
ADL = activities of daily life; AMPS =  Assessment of Motor and Process Skills; CI = confidence interval; COPM = Canadian Occupational Per-
formance Measure; PRISM = Pictorial Representation of Illness and Self Measure; Qol = quality of life; Ref = reference; SD = standard devia-
tion; VAS = visual analogue scale 
* Binary variable, effect presented as odds ratio 
† Overall p-value for an effect of time 
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Discussion 
The aim of this cohort study was to evaluate the short-, 
medium- and long-term effectiveness of the BAI-Reha 
programme, which is designed for patients with chronic 
musculoskeletal pain. The results revealed that the BAI-
Reha programme, lasting for 12 weeks was effective and 
that the effects remained stable in all but two outcomes 
for 2 years. 
The effect on return to work constantly increased after 
finishing the BAI-Reha up to the 2-year follow-up eval-
uation. More specifically, at baseline only 4 of 27 pa-
tients (15%) were integrated in regular work, post-treat-
ment 12 of 26 (46%) and at the 2-year follow-up 17 of 26 
(65%). We assume that the workplace interventions, in-
volving direct contact with the employer and negotiations 
about ergonomic workplace adaptations, as well as the 
slow return to work (e.g., constantly increasing working 
hours) was relevant for the significant progress in return 
to work. Our results are in line with the results of a recent 
Cochrane review by Hoving and colleagues, who found 
that job loss prevention interventions are potentially ef-
fective in reducing job loss and work absenteeism and 
improving work functioning in patients with inflamma-
tory arthritis [32]. The positive results in relation to work 
are not only important for the patients with chronic pain, 
but also for their families and society as a whole [1]. In 
future studies the outcome “return to work” could be one 
factor used to determine if an interprofessional pro-
gramme is cost-effective in patients with chronic pain 
[33]. 
Furthermore, the effect on burden of suffering, evaluated 
with the PRISM [26] was statistically significant up to 
the 2-year follow-up. Similar but less clear results were 
obtained for EuroQol [21, 22]. Together, this indicates a 
reduced burden of suffering [30] and an increased general 
health after the BAI Reha [21, 22]. 
However, we did not find any evidence for an influence 
of the BAI Reha programme on pain intensity. These re-
sults are in line with earlier studies showing very small 
effects or no effect of interprofessional programmes on 
the intensity of pain [e.g., 9, 10], and they underline the 
importance of focusing on coping strategies rather than 
reduction of pain intensity [34]. Accordingly, our pa-
tients were encouraged to focus on their individual goals 
and on increasing activity and participation (e.g., sports, 
work) and not on reduction of pain intensity. 
Performance of daily life tasks has rarely been addressed 
in recently published intervention studies. We found that 
the BAI-Reha programme had a positive effect on daily 
life and in particular on the self-rated quality of and sat-
isfaction with daily life task performance. This may well 
be explained by the goal-directed strategy of our rehabil-
itation programme. In the first COPM interview [25] the 
patients have to define their meaningful goals for activity 
and participation that subsequently remain the focus of 
the BAI-Reha. 
In agreement with this finding, BAI-Reha may also in-
crease the quality of ADL performance measured with 
the AMPS [24]. However, the effect was only found for 
ADL motor measures, which supports earlier findings 
that ADL process performance did not change [35] or 
only minimally changed [36] during an intervention. A 
possible explanation is that the quality of ADL process 
performance is not affected in persons with chronic mus-
culoskeletal pain. Accordingly, the mean ADL process 
performance measures of the participants in our study 
were in a normal range at the baseline evaluation. Pa-
tients with chronic pain may perform daily life tasks with 
increased physical effort and clumsiness (ADL motor 
performance) but with normal efficiency, safety and in-
dependence (ADL process performance) [35]. 
There are several statistical limitations of our study. Most 
importantly, a control group is lacking and it remains un-
known to what extent time may confound the analysis. 
Second, the sample size of 30 is very small. Third, asses-
sors were not independent and not blinded regarding time 
points of the programme. Finally, although data were col-
lected prospectively, they were stored in patient charts 
and transferred into the data base at the time of analysis 
only, making a re-assessment of missing data impossible. 
Our analyses included patients with partially missing 
data but missing data points were excluded (see table 3). 
Finally, the use of return to work as a primary outcome 
could be questioned. In future studies other outcomes to 
evaluate work functioning or sickness absenteeism [2] of 
persons with chronic pain should be included. 
In conclusion, this study confirms earlier data about a 
short-, medium-, and long-term effectiveness of an inter-
professional rehabilitation programme, the BAI-Reha 
programme for patients with chronic musculoskeletal 
pain. It adds new knowledge about the effect on return to 
work, burden of suffering and quality of and satisfaction 
with daily life task performance. 
Acknowledgements 
We thank the team who implemented the BAI-Reha: Schärer Huber Pia, Bach-
mann Stefan, Bill Hannelore, Caliezi Gion, Egender Barbara, Fluri Oliver, 
Helbling Barbara, Hertli Hueser Birgit, Kirchner Hanna, Marti Rebeka, Schütz 
Franziska, Schenker Erika, Stutz Ursula, Winteler Balz. 
Financial disclosure 
The study was funded by the Research Funds of the Department of Rheumatol-
ogy, Immunology, Allergology of the University Hospital (Inselspital) Bern and 
by an unrestricted research grant from Mundipharma Medical Company. 
Conflict of interest 
No other potential conflict of interest relevant to this article was reported. 
Correspondence: 
Brigitte Elisabeth Gantschnig 
Department of Rheumatology, Immunology and Allergology 




1 Wieser S, et al. Die Kosten der nichtübertragbaren Krankheiten in der 
Schweiz. Bern: Bundesamt für Gesundheit; 2014. 
2 Hoving JL, van Zwieten MC, van der Meer M, Sluiter JK, Frings-Dresen 
MH. Work participation and arthritis: a systematic overview of challenges, 
adaptations and opportunities for interventions. Rheumatology (Oxford). 
2013;52(7):1254–64. PubMed http://dx.doi.org/10.1093/rheumatol-
ogy/ket111 
3 Wolf LD, Davis MC. Loneliness, daily pain, and perceptions of interper-
sonal events in adults with fibromyalgia. Health Psychol. 2014;33(9):929–
37. PubMed http://dx.doi.org/10.1037/hea0000059 
4 Waehrens EE, Amris K, Fisher AG. Performance-based assessment of activ-
ities of daily living (ADL) ability among women with chronic widespread 
Swiss Medical Weekly · PDF of the online version · www.smw.ch   Page 7 of 7 
Published under the copyright license "Attribution - Non-Commercial - No Derivatives 4.0".  
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html. 
pain. Pain. 2010;150(3):535–41. PubMed 
http://dx.doi.org/10.1016/j.pain.2010.06.008 
5 Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Ko-
vacs F, et al.; COST B13 Working Group on Guidelines for Chronic Low 
Back Pain. Chapter 4. European guidelines for the management of chronic 
nonspecific low back pain. Eur Spine J. 2006;15(S2, Suppl 2):S192–300. 
PubMed http://dx.doi.org/10.1007/s00586-006-1072-1 
6 Kjeken I, Bø I, Rønningen A, Spada C, Mowinckel P, Hagen KB, et al. A 
three-week multidisciplinary in-patient rehabilitation programme had posi-
tive long-term effects in patients with ankylosing spondylitis: randomized 
controlled trial. J Rehabil Med. 2013;45(3):260–7. PubMed 
http://dx.doi.org/10.2340/16501977-1078 
7 Jensen IB, Bergström G, Ljungquist T, Bodin L. A 3-year follow-up of a 
multidisciplinary rehabilitation programme for back and neck pain. Pain. 
2005;115(3):273–83. PubMed http://dx.doi.org/10.1016/j.pain.2005.03.005 
8 Martín J, Torre F, Aguirre U, González N, Padierna A, Matellanes B, et al. 
Evaluation of the interdisciplinary PSYMEPHY treatment on patients with 
fibromyalgia: a randomized control trial. Pain Med. 2014;15(4):682–91. 
PubMed http://dx.doi.org/10.1111/pme.12375 
9 Castel A, Fontova R, Montull S, Periñán R, Poveda MJ, Miralles I, et al. Ef-
ficacy of a multidisciplinary fibromyalgia treatment adapted for women with 
low educational levels: a randomized controlled trial. Arthritis Care Res 
(Hoboken). 2013;65(3):421–31. PubMed 
http://dx.doi.org/10.1002/acr.21818 
10 Casanueva-Fernández B, Llorca J, Rubió JB, Rodero-Fernández B, Gonzá-
lez-Gay MA. Efficacy of a multidisciplinary treatment program in patients 
with severe fibromyalgia. Rheumatol Int. 2012;32(8):2497–502. PubMed 
http://dx.doi.org/10.1007/s00296-011-2045-1 
11 Lemstra M, Olszynski WP. The effectiveness of multidisciplinary rehabilita-
tion in the treatment of fibromyalgia: a randomized controlled trial. Clin J 
Pain. 2005;21(2):166–74. PubMed http://dx.doi.org/10.1097/00002508-
200503000-00008 
12 Monticone M, Ferrante S, Rocca B, Baiardi P, Farra FD, Foti C. Effect of a 
long-lasting multidisciplinary program on disability and fear-avoidance be-
haviors in patients with chronic low back pain: results of a randomized con-
trolled trial. Clin J Pain. 2013;29(11):929–38. PubMed 
http://dx.doi.org/10.1097/AJP.0b013e31827fef7e 
13 Monticone M, Ambrosini E, Rocca B, Magni S, Brivio F, Ferrante S. A 
multidisciplinary rehabilitation programme improves disability, kinesio-
phobia and walking ability in subjects with chronic low back pain: results of 
a randomised controlled pilot study. Eur Spine J. 2014;23(10):2105–13. 
PubMed http://dx.doi.org/10.1007/s00586-014-3478-5 
14 Nazzal ME, Saadah MA, Saadah LM, Al-Omari MA, Al-Oudat ZA, Nazzal 
MS, et al. Management options of chronic low back pain. A randomized 
blinded clinical trial. Neurosciences (Riyadh). 2013;18(2):152–9. PubMed 
15 Dufour N, Thamsborg G, Oefeldt A, Lundsgaard C, Stender S. Treatment of 
chronic low back pain: a randomized, clinical trial comparing group-based 
multidisciplinary biopsychosocial rehabilitation and intensive individual 
therapist-assisted back muscle strengthening exercises. Spine. 
2010;35(5):469–76. PubMed 
http://dx.doi.org/10.1097/BRS.0b013e3181b8db2e 
16 Henchoz Y, de Goumoëns P, So AK, Paillex R. Functional multidisciplinary 
rehabilitation versus outpatient physiotherapy for non specific low back 
pain: randomized controlled trial. Swiss Med Wkly. 2010;140:w13133. 
https://smw.ch/en/archives/article/?tx_ezmjournal_articledetail[identi-
fier]=smw.2010.13133 PubMed 
17 Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary in-
tervention in the treatment of migraine: a randomized clinical trial. Head-
ache. 2002;42(9):845–54. PubMed http://dx.doi.org/10.1046/j.1526-
4610.2002.02202.x 
18 Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJ, Ostelo RW, Guzman J, 
et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back 
pain. Cochrane Database Syst Rev. 2014;(9):CD000963. 
doi:10.1002/14651858.CD000963.pub3. PubMed 
19 Artus M, van der Windt D, Jordan KP, Croft PR. The clinical course of low 
back pain: a meta-analysis comparing outcomes in randomised clinical trials 
(RCTs) and observational studies. BMC Musculoskelet Disord. 
2014;15(1):68. PubMed http://dx.doi.org/10.1186/1471-2474-15-68 
20 World Health Organisation. ICD-10. Internationale statistische Klassifika-
tion der Krankheiten und verwandter Gesundheitsprobleme. 10. Revision. 
Köln: Deutschen Institut für Medizinische Dokumentationund Information; 
2013. 
21 EuroQol Group. EuroQol-a new facility for the measurement of health-re-
lated quality of life. Health Policy. 1990;16(3):199–208. 
22 EuroQol Group. EQ-5D-3L User Guide. Basic information on how to use 
the EQ-5D-3L instrument. Rotterdam: EuroQoL Group; 2013. p. 199–208. 
23 Cleland JA, Childs JD, Whitman JM. Psychometric properties of the Neck 
Disability Index and Numeric Pain Rating Scale in patients with mechanical 
neck pain. Arch Phys Med Rehabil. 2008;89(1):69–74. PubMed 
http://dx.doi.org/10.1016/j.apmr.2007.08.126 
24 Fisher AG, Jones KB. Assessment of Motor and Process Skills: Develop-
ment, standardization, and administration manual. 7th Revised ed. Vol. I. 
Fort Collins, CO: Three Star Press; 2012. 
25 Law M, et al. COPM. Canadian Occupational Performance Measure. 4th ed. 
Idstein: Schulz-Kirchner Verlag GmbH; 2009. 
26 Streffer ML, Büchi S, Mörgeli H, Galli U, Ettlin D. PRISM (pictorial repre-
sentation of illness and self measure): a novel visual instrument to assess 
pain and suffering in orofacial pain patients. J Orofac Pain. 2009;23(2):140–
6. PubMed 
27 Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 
dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire 
in chronic pain. Health Qual Life Outcomes. 2013;11(1):110. PubMed 
http://dx.doi.org/10.1186/1477-7525-11-110 
28 Gantschnig BE, Page J, Fisher AG. Cross-regional validity of the assess-
ment of motor and process skills for use in middle Europe. J Rehabil Med. 
2012;44(2):151–7. PubMed http://dx.doi.org/10.2340/16501977-0915 
29 Weidt S, Bruehl AB, Moergeli H, Straumann D, Hegemann S, Büchi S, et 
al. Graphic representation of the burden of suffering in dizziness patients. 
Health Qual Life Outcomes. 2014;12(1):184. PubMed 
http://dx.doi.org/10.1186/s12955-014-0184-2 
30 Kassardjian CD, Gardner-Nix J, Dupak K, Barbati J, Lam-McCullock J. 
Validating PRISM (Pictorial Representation of Illness and Self Measure) as 
a measure of suffering in chronic non-cancer pain patients. J Pain. 
2008;9(12):1135–43. PubMed http://dx.doi.org/10.1016/j.jpain.2008.06.016 
31 UNESCO Institute for Statistics. International Standard Classification of Ed-
ucation. ISCE 2011. Montreal: UNESCO Institute for Statistics; 2012.  
32 Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen 
MH. Non-pharmacological interventions for preventing job loss in workers 
with inflammatory arthritis. Cochrane Database Syst Rev. 
2014;(11):CD010208. doi:10.1002/14651858.CD010208.pub2. PubMed 
33 Drummond MF, et al. Methods for the economic evaluation of health care 
programmes. 3rd ed. Oxford: Oxford University Press; 2005. 
34 Verra ML, Angst F, Brioschi R, Lehmann S, Benz T, Aeschlimann A, et al. 
Effectiveness of subgroup-specific physiotherapy: a randomized controlled 
trial with one-year follow up in persons with chronic back pain. Physiother-
apy. 2015;101(Supplement 1):e1586–7. 
http://dx.doi.org/10.1016/j.physio.2015.03.1592 
35 Wæhrens EE. Measuring quality of occupational performance based on self-
report and observation. Development and validation of instruments to evalu-
ate ADL task performance, in department of community medicine and reha-
bilitation, occupational therapy. Umeå: Umeå University Press; 2010. 
36 Amris K, Wæhrens EE, Christensen R, Bliddal H, Danneskiold-Samsøe B; 
IMPROvE Study Group. Interdisciplinary rehabilitation of patients with 
chronic widespread pain: primary endpoint of the randomized, nonblinded, 
parallel-group IMPROvE trial. Pain. 2014;155(7):1356–64. PubMed 
http://dx.doi.org/10.1016/j.pain.2014.04.012 
 
